Roshan Agarwal
Overview
Explore the profile of Roshan Agarwal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
2512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Baird R, Banks I, Cameron D, Chester J, Earl H, Flannagan M, et al.
Ecancermedicalscience
. 2016 Feb;
10:608.
PMID: 26913066
The Association of Cancer Physicians in the United Kingdom has developed a strategy to improve outcomes for cancer patients and identified the goals and commitments of the Association and its...
12.
Gungor H, Saleem A, Babar S, Dina R, El-Bahrawy M, Curry E, et al.
J Nucl Med
. 2015 Oct;
56(12):1828-35.
PMID: 26429956
Unlabelled: AKT (a serine/threonine-specific protein kinase) regulates many cellular processes contributing to cytotoxic drug resistance. This study's primary objective examined the relationship between GSK2141795, an oral, pan-AKT inhibitor, and (18)F-FDG...
13.
Robertson L, Yeoh S, Stansby G, Agarwal R
Cochrane Database Syst Rev
. 2015 Mar;
(3):CD010837.
PMID: 25749503
Background: Venous thromboembolism (VTE) is a collective term for two conditions: deep vein thrombosis (DVT) and pulmonary embolism (PE). A proportion of patients with VTE have no underlying or immediately...
14.
Agarwal R, Alifrangis C, Everard J, Savage P, Short D, Tidy J, et al.
J Reprod Med
. 2014 Mar;
59(1-2):7-12.
PMID: 24597279
Objective: To present survival rates of high-risk gestational trophoblastic neoplasia (GTN) (FIGO score > 7) patients treated between 1995 and 2010 in the U.K. Death due to GTN is largely...
15.
Witney T, Carroll L, Alam I, Chandrashekran A, Nguyen Q, Sala R, et al.
Cancer Res
. 2014 Mar;
74(5):1319-28.
PMID: 24590807
The high rate of glucose uptake to fuel the bioenergetic and anabolic demands of proliferating cancer cells is well recognized and is exploited with (18)F-2-fluoro-2-deoxy-d-glucose positron emission tomography ((18)F-FDG-PET) to...
16.
Shaw P, Agarwal R
Cochrane Database Syst Rev
. 2013 Nov;
(11):CD002916.
PMID: 24259053
No abstract available.
17.
OCathail S, Shaboodien R, Mahmoud S, Carty K, OSullivan P, Blagden S, et al.
Int J Gynecol Cancer
. 2013 Aug;
23(7):1318-25.
PMID: 23907557
Objective: Dexamethasone premedication is required with paclitaxel to prevent infusion-related hypersensitivity reactions (HSRs). Both oral dexamethasone (PO-D; 20 mg 12 and 6 hours before paclitaxel) and intravenous dexamethasone (IV-D; 20...
18.
Payne S, Burke D, Mansi J, Jones A, Norton A, Joffe J, et al.
Clin Med (Lond)
. 2013 Mar;
13(1):50-6.
PMID: 23472496
The impact of cancer on healthcare is increasing. Therefore, it is key that all doctors receive oncology training. This study surveyed UK undergraduate medical schools to determine the extent of...
19.
Shaboodien R, Diamantis N, Blagden S, Gabra H, Agarwal R
Int J Gynecol Cancer
. 2013 Feb;
23(3):481-7.
PMID: 23392404
Background: To rapidly evaluate the significant numbers of novel therapies entering clinical development requires maximization of clinical trial capacity. To enable this, we evaluated the profile of patients with epithelial...
20.
Stavraka C, Maclaran K, Gabra H, Agarwal R, Ghaem-Maghami S, Taylor A, et al.
Oncologist
. 2013 Feb;
18(4):423-9.
PMID: 23363808
Background: An association between treatment for gynecological cancers and risk of osteoporosis has never been formally evaluated. Women treated for these cancers are now living longer than ever before, and...